Cytokine Storms and Silent Killers: Immune Dysregulation in Cancer Progression

Authors

  • Awais Ali Department of Biochemistry, Abdul Wali Khan University, Mardan, Pakistan Author

DOI:

https://doi.org/10.64229/74pkkk80

Keywords:

Cytokine storm, Tumor microenvironment, Immune dysregulation, Cancer immunotherapy, Inflammation, Immune checkpoints

Abstract

Cytokines are central mediators of immune communication, orchestrating interactions between innate and adaptive immune cells. In cancer, dysregulated cytokine signaling drives chronic inflammation, immune suppression, and tumor progression. This narrative review synthesizes current mechanistic and clinical insights into cytokine dysregulation, explicitly distinguishing acute systemic cytokine release syndrome (CRS), often observed during CAR-T cell therapy, from chronic, tumor-localized cytokine amplification within the tumor microenvironment (TME). We discuss key signaling pathways including IL-6/STAT3, TNF-α/NF-κB, and TGF-β/SMAD highlighting context-, tumor-, and dose-dependent effects on epithelial-to-mesenchymal transition (EMT), therapy resistance, immune exhaustion, and angiogenesis. The review integrates translational evidence linking cytokine activity to tumor type, biomarkers, patient stratification, and outcomes from both successful and failed clinical trials. Conceptual schematics and tables provide visual summaries of cytokine interactions, immunosuppressive networks, and therapeutic targets. Limitations, including the non-novel nature of the mechanisms discussed, selective clinical coverage, and context-specific variability, are explicitly addressed. By consolidating mechanistic and clinical knowledge, this review offers a focused perspective on cytokine dysregulation, informing translational strategies to modulate the tumor immune landscape.

References

[1]Guan YJ, Li ML, Qiu ZD, Xu JH, Zhang YC, Hu N, et al. Comprehensive analysis of DOK family genes expression, immune characteristics, and drug sensitivity in human tumors. Journal of Advanced Research, 36, 73-87. DOI: 10.1038/ncomms11290

[2]Yan XH, Qi M, Li PF, Zhan YH, Shao HJ. Apigenin in cancer therapy: Anti-cancer effects and mechanisms of action. Cell & Bioscience, 2017, 7(50). DOI: 10.1186/s13578-017-0179-x

[3]Paranga TG, Mitu I, Pavel-Tanasa M, Rosu MF, Miftode IL, Constantinescu D, et al. Cytokine storm in COVID-19: Exploring IL-6 signaling and cytokine-microbiome interactions as emerging therapeutic approaches. International Journal of Molecular Sciences, 2024, 25(21), 11411. DOI: 10.3390/ijms252111411

[4]Huard B, Tournier M, Hercend T, Triebel F, Faure F. Lymphocyte-activation gene 3/major histocompatibility complex class II interaction modulates the antigenic response of CD4+ T lymphocytes. European Journal of Immunology, 24(12), 3216-3221. DOI: 10.1002/eji.1830241246

[5]Razizadeh MH, Zafarani A, Taghavi-Farahabadi M, Khorramdelazad H, Minaeian S, Mahmoudi M. Natural killer cells and their exosomes in viral infections and related therapeutic approaches: Where are we? Cell Communication and Signaling, 2023, 21(1), 261. DOI: 10.1186/s12964-023-01266-2

[6]Ali A, Alamri A, Hajar A. NK/DC crosstalk-modulating antitumor activity via Sema3E/PlexinD1 axis for enhanced cancer immunotherapy. Immunologic Research, 2024, 72(6), 1217-1228. DOI: 10.1007/s12026-024-09536-y

[7]Zhao X, Subramanian S. Intrinsic resistance of solid tumors to immune checkpoint blockade therapy. Cancer Research, 2017, 77(4), 817-822. DOI: 10.1158/0008-5472.CAN-16-2379

[8]Mir SA, Dar A, Hamid L, Nisar N, Malik JA, Ali T, et al. Flavonoids as promising molecules in the cancer therapy: An insight. Current Research in Pharmacology and Drug Discovery, 2024, 6, 100167. DOI: 10.1016/j.crphar.2023.100167

[9]Andrews LP, Butler SC, Cui J, Cillo AR, Cardello C, Liu C, et al. LAG-3 and PD-1 synergize on CD8+ T cells to drive T cell exhaustion and hinder autocrine IFN-γ-dependent anti-tumor immunity. Cell, 2024, 187(16), 4355-4372. DOI: 10.1016/j.cell.2024.07.016

[10]Patel A, Jain P, Ajazuddin. Recent advances in the therapeutics and modes of action of a range of agents used to treat ulcerative colitis and related inflammatory conditions. Inflammopharmacology, 2025, 33(9), 4965-4996. DOI: 10.1007/s10787-025-01906-8

[11]Ladislau L, Portilho DM, Courau T, Solares-Pérez A, Negroni E, Lainé J, et al. Activated dendritic cells modulate proliferation and differentiation of human myoblasts. Cell Death & Disease, 2018, 9, 551. DOI: 10.1038/s41419-018-0426-z

[12]Baru Venkata R, Prasanth DSNBK, Pasala PK, Pasala PK, Panda SP, Tatipamula VB, et al. Utilizing andrographis paniculata leaves and roots by effective usage of the bioactive andrographolide and its nanodelivery: Investigation of antikindling and antioxidant activities through in silico and in vivo studies. Frontiers in Nutrition, 2023, 10, 1185236. DOI: 10.3389/fnut.2023.1185236

[13]Ali A, Ali SL, Ullah W, Khan A. Gene expression profiling identifies CAV1, CD44, and TFRC as potential diagnostic markers and therapeutic targets for multiple myeloma. Cell Biochemistry and Biophysics, 2025, 83, 3633-3650. DOI: 10.1007/s12013-025-01743-0

[14]Ali SL, Ali A, Khan A. Identification and assessment of ferroptosis-related genes and their implication as therapeutic agents for pancreatic ductal adenocarcinoma. Annals of Pancreatic Cancer, 2025, 8. DOI: 10.21037/apc-25-2

[15]Hayes RL, Koslow M, Hiesiger EM, Hymes KB, Hochster HS, Moore EJ, et al. Improved long term survival after intracavitary interleukin‐2 and lymphokine‐activated killer cells for adults with recurrent malignant glioma. Cancer, 76(5), 840-852. DOI: 10.1002/1097-0142(19950901)76:5<840::aid-cncr2820760519>3.0.co;2-r

[16]Andrews LP, Marciscano AE, Drake CG, Vignali DAA. LAG3 (CD223) as a cancer immunotherapy target. Immunological Reviews, 2017, 276(1), 80-96. DOI: 10.1111/imr.12519

[17]Lu JX, Lu ZX, Liu LX, Li XY, Yu WG, Lu XZ. Identification of crocin as a New hIAPP amyloid inhibitor via a simple yet highly biospecific screening system. Chemistry & Biodiversity, 2021, 18(6), e2100270. DOI: 10.1002/cbdv.202100270

[18]Pugliese D, Privitera G, Fiorani M, Parisio L, Calvez V, Papa A, et al. Targeting IL12/23 in ulcerative colitis: Update on the role of ustekinumab. Therapeutic Advances in Gastroenterology, 2022, 15, 17562848221102284. DOI: 10.1177/17562848221102283

[19]Krähling V, Erbar S, Kupke A, Nogueira SS, Walzer KC, Berger H, et al. Self-amplifying RNA vaccine protects mice against lethal Ebola virus infection. Molecular Therapy, 2023, 31(2), 374-386. DOI: 10.1016/j.ymthe.2022.10.011

[20]Vaninov N. In the eye of the COVID-19 cytokine storm. Nature Reviews Immunology, 2020, 20, 277. DOI: 10.1038/s41577-020-0305-6

[21]Boor PPC, Metselaar HJ, Jonge S de, Mancham S, der Laan, van der Laan LJW, et al. Human plasmacytoid dendritic cells induce CD8+ LAG-3+ Foxp3+ CTLA-4+ regulatory T cells that suppress allo-reactive memory T cells. European Journal of Immunology, 2011, 41(6), 1663-1674. DOI: 10.1002/eji.201041229

[22]Vaure C, Liu YQ. A comparative review of toll-like receptor 4 expression and functionality in different animal species. Frontiers in Immunology, 2014, 5, 316. DOI: 10.3389/fimmu.2014.00316

[23]Kawai T, Akira S. Signaling to NF-κB by Toll-like receptors. Trends in Molecular Medicine, 2007, 13(11), 460-469. DOI: 10.1016/j.molmed.2007.09.002

[24]Hu XY, Chakravarty SD, Ivashkiv LB. Regulation of interferon and Toll‐like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms. Immunological Reviews, 2008, 226, 41-56. DOI: 10.1111/j.1600-065X.2008.00707.x

[25]Camisaschi C, De Filippo A, Beretta V, Vergani B, Villa A, Vergani E, et al. Alternative activation of human plasmacytoid DCs in vitro and in melanoma lesions: Involvement of LAG-3. The Journal of Investigative Dermatology, 2014, 134(7), 1893-1902. DOI: 10.1038/jid.2014.29

[26]Pampena MB, Levy EM. Natural killer cells as helper cells in dendritic cell cancer vaccines. Frontiers in Immunology, 2015, 6, 13. DOI: 10.3389/fimmu.2015.00013

[27]Di Carlo E, Cappello P, Sorrentino C, D'Antuono T, Pellicciotta A, Giovarelli M, et al. Immunological mechanisms elicited at the tumour site by lymphocyte activation gene-3 (LAG-3) versus IL-12: Sharing a common Th1 anti-tumour immune pathway. The Journal of Pathology, 2005, 205(1), 82-91. DOI: 10.1002/path.1679

[28]Kritikou JS, Dahlberg CIM, Baptista MAP, Wagner AK, Banerjee PP, Gwalani LA, et al. IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo. Scientific Reports, 2016, 6, 30636. DOI: 10.1038/srep30636

[29]Peña J, Jones NG, Bousheri S, Bangsberg DR, Cao HY. Lymphocyte activation gene-3 expression defines a discrete subset of HIV-specific CD8+ T cells that is associated with lower viral load. AIDS Research and Human Retroviruses, 2014, 30(6), 535-541. DOI: 10.1089/aid.2012.0195

[30]Olubode SO, Omotuyi OI, Fadipe DO. Computational prediction of HCV RNA polymerase inhibitors from alkaloid library. Letters in Applied NanoBioScience, 2022, 11(3), 3661-3671. DOI: 10.33263/lianbs113.36613671

[31]Aydemir TB, Troche C, Kim J, Kim MH, Teran OY, Leeuwenburgh C, et al. Aging amplifies multiple phenotypic defects in mice with zinc transporter Zip14 (Slc39a14) deletion. Experimental Gerontology, 85, 88-94. DOI: 10.1016/j.exger.2016.09.013

[32]Gravina AG, Pellegrino R, Esposito A, Cipullo M, Romeo M, Palladino G, et al. The JAK-STAT pathway as a therapeutic strategy in cancer patients with immune checkpoint inhibitor-induced colitis: A narrative review. Cancers, 2024, 16(3), 611. DOI: 10.3390/cancers16030611

[33]Yu YF, Yan R, Chen XZ, Sun T, Yan JF. Paeonol suppresses the effect of ox-LDL on mice vascular endothelial cells by regulating miR-338-3p/TET2 axis in atherosclerosis. Molecular and Cellular Biochemistry, 2020, 475, 127-135. DOI: 10.1007/s11010-020-03865-w

[34]Hinshaw DC, Shevde LA. The tumor microenvironment innately modulates cancer progression. Cancer Research, 2019, 79(18), 4557-4566. DOI: 10.1158/0008-5472.CAN-18-3962

[35]Zhu XF, Yang PZ, Zhou HY, Li B, Huang XK, Mang QL, et al. CD4+CD25+Tregs express an increased LAG-3 and CTLA-4 in anterior chamber-associated immune deviation. Graefe's Archive for Clinical and Experimental Ophthalmology, 2007, 245, 1549-1557. DOI: 10.1007/s00417-007-0591-8

[36]Mishra AK, Kadoishi T, Wang XG, Driver E, Chen ZG, Wang XJ, et al. Squamous cell carcinomas escape immune surveillance via inducing chronic activation and exhaustion of CD8+ T Cells co-expressing PD-1 and LAG-3 inhibitory receptors. Oncotarget, 2016, 7(49), 81341-81356. DOI: 10.18632/oncotarget.13228

[37]Hu B, Gao J, Shi JH, Zhang F, Shi CC, Wen PH, et al. Necroptosis throws novel insights on patient classification and treatment strategies for hepatocellular carcinoma. Frontiers in Immunology, 2022, 13, 970117. DOI: 10.3389/fimmu.2022.970117

[38]Gu CW, Hou CZ, Zhang S. miR-425-5p improves inflammation and septic liver damage through negatively regulating the RIP1-mediated necroptosis. Inflammation Research, 2020, 69, 299-308. DOI: 10.1007/s00011-020-01321-5

[39]Tan LL, Wang SF, Chang WL, Zhang XY, Deng R, Yan HF, et al. Role of necroptosis-related genes in immune activity and prognosis of colorectal cancer. Frontiers in Immunology, 2025, 16, 1619749. DOI: 10.3389/fimmu.2025.1619749

[40]Zhen Y, Zhang H. NLRP3 inflammasome and inflammatory bowel disease. Frontiers in Immunology, 2019, 10, 276. DOI: 10.3389/fimmu.2019.00276

[41]Biasizzo M, Kopitar-Jerala N. Interplay between NLRP3 inflammasome and autophagy. Frontiers in Immunology, 2020, 11, 591803. DOI: 10.3389/fimmu.2020.591803

[42]Ali SL, Ali A, Alamri A, Baiduissenova A, Dusmagambetov M, Abduldayeva A. Genomic annotation for vaccine target identification and immunoinformatics-guided multi-epitope-based vaccine design against songling virus through screening its whole genome encoded proteins. Frontiers in Immunology, 14, 1284366. DOI: 10.3389/fimmu.2023.1284366

[43]Wang XN, Tian YT, Li CM, Chen M. Exploring the key ferroptosis-related gene in the peripheral blood of patients with Alzheimer’s disease and its clinical significance. Frontiers in Aging Neuroscience, 2022, 14, 970796. DOI: 10.3389/fnagi.2022.970796

[44]Paula FS, Kabeya LM, Kanashiro A, de Figueiredo ASG, Azzolini AECS, Uyemura SA, et al. Modulation of human neutrophil oxidative metabolism and degranulation by extract of Tamarindus indica L. fruit pulp. Food and Chemical Toxicology, 2009, 47(1), 163-170. DOI: 10.1016/j.fct.2008.10.023

[45]Kałużna A, Olczyk P, Komosińska-Vassev K. The role of innate and adaptive immune cells in the pathogenesis and development of the inflammatory response in ulcerative colitis. Journal of Clinical Medicine, 2022, 11(2), 400. DOI: 10.3390/jcm11020400

[46]Ndisang JF. Role of heme oxygenase in inflammation, insulin-signalling, diabetes and obesity. Mediators of Inflammation, 2010, 2010, 359732. DOI: 10.1155/2010/359732

[47]Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao N, et al. Ferroptosis: Past, present and future. Cell Death & Disease, 2020, 11(2), 88. DOI: 10.1038/s41419-020-2298-2

[48]Mahmud S, Paul GK, Afroze M, Islam S, Gupt SBR, Razu MH, et al. Efficacy of phytochemicals derived from avicennia officinalis for the management of covid-19: A combined in silico and biochemical study. Molecules, 2021, 26(8), 2210. DOI: 10.3390/molecules26082210

[49]Brignone C, Gutierrez M, Mefti F, Brain E, Jarcau R, Cvitkovic et al. First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity. Journal of Translational Medicine, 2010, 8, 71. DOI: 10.1186/1479-5876-8-71

[50]Vilgelm AE, Johnson DB, Richmond A. Combinatorial approach to cancer immunotherapy: Strength in numbers. Journal of Leukocyte Biology, 2016, 100(2), 275-290. DOI: 10.1189/jlb.5RI0116-013RR

[51]Bjoern J, Lyngaa R, Andersen R, Hölmich LR, Hadrup SR, Donia M, et al. Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma. Oncotarget, 2017, 8(16), 27062-27074. DOI: 10.18632/oncotarget.16003

[52]Lin C, Sun L, Huang SL, Weng XQ,Wu ZX. STC2 is a potential prognostic biomarker for pancreatic cancer and promotes migration and invasion by inducing epithelial-mesenchymal transition. BioMed Research International, 2019, 2019, 8042489. DOI: 10.1155/2019/8042489

[53]Khan R, Pari B, Puszynski K. Comprehensive bioinformatic investigation of TP53 dysregulation in diverse cancer landscapes. Genes, 2024, 15(5), 577. DOI: 10.3390/genes15050577

[54]Hannier S, Tournier M, Bismuth G, Triebel F. CD3/TCR complex-associated lymphocyte activation gene-3 molecules inhibit CD3/TCR signaling. Journal of Immunology, 1998, 161(8), 4058-4065.DOI: 10.4049/jimmunol.161.8.4058

[55]Park HJ, Kusnadi A, Lee EJ, Kim WW, Cho BC, Lee IJ, et al. Tumor-infiltrating regulatory T cells delineated by upregulation of PD-1 and inhibitory receptors. Cellular Immunology, 2012, 278, 76-83. DOI: 10.1016/j.cellimm.2012.07.001

[56]Watanabe H, Enoki Y, Maruyama T. Sarcopenia in chronic kidney disease: Factors, mechanisms, and therapeutic interventions. Biological & Pharmaceutical Bulletin, 2019, 42(9), 1437-1445. DOI: 10.1248/bpb.b19-00513

[57]Huard B, Tournier M, Triebel F. LAG-3 does not define a specific mode of natural killing in human. Immunology Letters, 1998, 61(2-3), 109-112. DOI: 10.1016/s0165-2478(97)00170-3

[58]Zhan Y, Brown C, Maynard E, Anshelevich A, Ni W, Ho IC, et al. Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. The Journal of Clinical Investigation, 115(9), 2508-2516. DOI: 10.1172/JCI24403

[59]Jha V, Workman CJ, McGaha TL, Li LP, Vas J, Vignali DAA, et al. Lymphocyte activation gene-3 (LAG-3) negatively regulates environmentally-induced autoimmunity. PLoS One, 9(8), e104484. DOI: 10.1371/journal.pone.0104484

[60]Sun HY, Sun C, Xiao WH. Expression regulation of co-inhibitory molecules on human natural killer cells in response to cytokine stimulations. Cytokine, 2014, 65(1), 33-41. DOI: 10.1016/j.cyto.2013.09.016

[61]Cai YL, Xu L, Xu CX, Wang YG, Fan CH. Hsa_circ_0001445 inhibits ox-LDL-induced HUVECs inflammation, oxidative stress and apoptosis by regulating miRNA-640. Perfusion, 2022, 37(1), 86-94. DOI: 10.1177/0267659120979472

[62]Villarroel-Espindola F, Yu XQ, Datar I, Mani N, Sanmamed M, Velcheti V, et al. Spatially resolved and quantitative analysis of VISTA/PD-1H as a novel immunotherapy target in human non-small cell lung cancer. Clinical Cancer Research, 2018, 24(7), 1562-1573. DOI: 10.1158/1078-0432.CCR-17-2542

[63]Ali SL, Ali A, Alamri A, Baiduissenova A, Dusmagambetov M, Abduldayeva A. Genomic annotation for vaccine target identi fi cation and multi-epitope-based vaccine design against Songling virus through screening its whole genome encoded proteins. Frontiers in Immunology, 2023, 14, 1284366. DOI: 10.3389/fimmu.2023.1284366

[64]Dinh P, Tran C, Dinh T, Ha HA, Utegenova A, Ali A, et al. Identification and assessment of hub genes and miRNAs coregulatory associated with immune infiltrations and drug interactions in latent tuberculosis based on MicroarrayData analysis, molecular docking, and dynamic simulation. Biochemistry and Biophysics Reports, 41, 101952. DOI: 10.1016/j.bbrep.2025.101952

[65]Geng HH, Li R, Su YM, Xiao J, Pan M, Cai XX, et al. The circular RNA Cdr1as promotes myocardial infarction by mediating the regulation of miR-7a on its target genes expression. PLoS One, 2016, 11, e0151753. DOI: 10.1371/journal.pone.0151753

[66]Farsam V, Hassan ZM, Zavaran-Hosseini A, Noori S, Mahdavi M, Ranjbar M. Antitumor and immunomodulatory properties of artemether and its ability to reduce CD4+ CD25+ FoxP3+ T reg cells in vivo. International Immunopharmacolog, 2011, 11(11), 1802-1808. DOI: 10.1016/j.intimp.2011.07.008

[67]Fu AZ, Wang Q, Mu JL, Ma LL, Wen CL, Zhao XY, et al. Combined genomic, transcriptomic, and metabolomic analyses provide insights into chayote (Sechium edule) evolution and fruit development. Horticulture Research, 2021, 8, 35. DOI: 10.1038/s41438-021-00487-1

[68]Bruniquel D, Borie N, Hannier S, Triebel F. Regulation of expression of the human lymphocyte activation gene-3 (LAG-3) molecule, a ligand for MHC class II. Immunogenetics, 1998, 48(2), 116-124. DOI: 10.1007/s002510050411

[69]Choueiri TK, Kaelin Jr WG. Targeting the HIF2-VEGF axis in renal cell carcinoma. Nature Medicine, 2020, 26, 1519-1530. DOI: 10.1038/s41591-020-1093-z

[70]Ali A, Luqman Ali S. A stable mRNA-based novel multi-epitope vaccine designs against infectious heartland virus by integrated immunoinformatics and reverse vaccinology approaches. Viral Immunology, 2025, 38(3). DOI: 10.1089/vim.2025.0004

[71]Ali A, Alamri A, Ullah W, Waseem T, Ali SL, AI Arian T, et al. Terpenoids modulation of the IFI16-AIM2 interaction for enhanced immune response in lung squamous cell carcinoma and AIM2-dysregulated diseases. In Silico Pharmacology, 2025, 13, 174. DOI: 10.1007/s40203-025-00453-y

[72]Ali SL, Ali A, Ullah W, Khan A, Khatrawi EM, Malik A, et al. Promising vaccine models against astrovirus MLB2 using integrated vaccinomics and immunoinformatics approaches. Molecular Systems Design & Engineering, 2024, 12. DOI: 10.1039/D3ME00192J

[73]Ali SL, Ali A, Khan A. Design of chimera vaccine against cutavirus using vaccinomics and immunoinformatics approaches. In Silico Pharmacology, 2025, 13, 172. DOI: 10.1007/s40203-025-00467-6

[74]Hajar A, Swathi NL, Ali A. Immunological insights into nutritional deficiency disorders. Causes and Management of Nutritional Deficiency Disorders, 2024, 60-83. DOI: 10.4018/979-8-3693-2947-4.ch004

[75]Oji Y, Ogawa H, Tamaki H, Oka Y, Tsuboi A, Kim EH, et al. Expression of the Wilms’ tumor gene WT1 in solid tumors and its involvement in tumor cell growth. Japanese Journal of Cancer Research, 90(2), 194-204. DOI: 10.1111/j.1349-7006.1999.tb00733.x.

[76]Peng H, Kaplan N, Lavker RM. 900 single cell RNA seq (scRNA-seq) defines the early and late corneal epithelial transit amplifying (TA) cells. Journal of Investigative Dermatology, 2019, 139(5), S155. DOI: 10.1016/j.jid.2019.03.976

[77]Tran E, Turcotte S, Gros A, Robbins PF, Lu YC, Dudley ME, et al. Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer. Science, 2014, 344(6184), 641-645. DOI: 10.1126/science.1251102

[78]Wiernicki B, Maschalidi S, Pinney J, Adjemian S, Berghe TV, Ravichandran KS, et al. Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity. Nature Communications, 13, 3676. DOI: 10.1038/s41467-022-31218-2

[79]Fukuda K, Okamura K, Riding RL, Fan XL, Afshari K, Haddadi NS, et al. AIM2 regulates anti-tumor immunity and is a viable therapeutic target for melanoma. The Journal of Experimental Medicine, 2021, 218(9), e20200962. DOI: 10.1084/jem.20200962

[80]Ning JB, Wang YT, Tao ZJ. The complex role of immune cells in antigen presentation and regulation of T-cell responses in hepatocellular carcinoma: progress, challenges, and future directions. Frontiers in Immunology, 2024, 15, 1483834. DOI: 10.3389/fimmu.2024.1483834

[81]Hoffmann E, Kotsias F, Visentin G, Bruhns P, Savina A, Amigorena S. Autonomous phagosomal degradation and antigen presentation in dendritic cells. Proceedings of the National Academy of Sciences of the United States of America, 2012, 109(36), 14556-14561. DOI: 10.1073/pnas.1203912109

[82]Regnault A, Lankar D, Lacabanne V, Rodriguez A, Théry C, Rescigno M, et al. Fcγ receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. The Journal of Experimental Medicine, 1999, 189(2), 371-380. DOI: 10.1084/jem.189.2.371

[83]Lev-Maor G, Sorek R, Shomron N, Ast G. The birth of an alternatively spliced exon: 3’ splice-site selection in Alu exons. Science, 2003, 300(5623), 1288-1291. DOI: 10.1126/science.1082588

[84]Sen P, Roy Acharyya S, Arora A, Ghosh SS. An in-silico approach to understand the potential role of Wnt inhibitory factor-1 (WIF-1) in the inhibition of the Wnt signalling pathway. Journal of Biomolecular Structure & Dynamics, 2024, 42(1), 326-345. DOI: 10.1080/07391102.2023.2192810

[85]Khan MN, Mao BL, Hu J, Shi MJ, Wang SY, Rehman AU, et al. Tumor-associated macrophages and CD8+ T cells: Dual players in the pathogenesis of HBV-related HCC. Frontiers in Immunology, 2024, 15, 1472430. DOI: 10.3389/fimmu.2024.1472430

[86]Das M, Zhu C, Kuchroo VK. Tim-3 and its role in regulating anti-tumor immunity. Immunological Reviews, 276(1), 97-111. DOI: 10.1111/imr.12520

[87]Chen XH, Liu JB, He B, Li YF, Liu SY, Wu B, et al. Vascular endothelial growth factor (VEGF) regulation by hypoxia inducible factor-1 alpha (HIF1A) starts and peaks during endometrial breakdown, not repair, in a mouse menstrual-like model. Human Reproduction, 2015, 30(9), 2160-2170. DOI: 10.1093/humrep/dev156

[88]Kim J, Oh W-J, Gaiano N, Yoshida Y, Gu CH. Semaphorin 3E-Plexin-D1 signaling regulates VEGF function in developmental angiogenesis via a feedback mechanism. Genes & Development, 2011, 25(13), 1399-1411. DOI: 10.1101/gad.2042011

[89]Wang Y, Zhao RZ, Shen CY, Liu WW, Yuan JS, Li CF, et al. Exosomal circHIPK3 released from hypoxia-induced cardiomyocytes regulates cardiac angiogenesis after myocardial infarction. Oxidative Medicine and Cellular Longevity, 2020, 2020, 8418407. DOI: 10.1155/2020/8418407

[90]Andreae S, Buisson S, Triebel F. MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223). Blood, 2003, 102(6), 2130-2137. DOI: 10.1182/blood-2003-01-0273

[91]Conche C, Finkelmeier F, Pešić M, Nicolas AM, Böttger TW, Kennel KB, et al. Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade. Gut, 2023, 72(9), 1774-1782. DOI: 10.1136/gutjnl-2022-327909

[92]Cheng FX, Li WH, Liu GX, Tang Y. In silico ADMET prediction: recent advances, current challenges and future trends. Current Topics in Medicinal Chemistry, 2013, 13(11), 1273-1289. DOI: 10.2174/15680266113139990033

[93]Ramasamy K, Samayoa C, Krishnegowda N, Tekmal RR. Therapeutic use of estrogen receptor β agonists in prevention and treatment of endocrine therapy resistant breast cancers: Observations from preclinical models. Progress in Molecular Biology and Translational Science,2017, 151, 177-194. DOI: 10.1016/bs.pmbts.2017.08.002

[94]Hailman E, Lichenstein HS, Wurfel MM, Miller DS, Johnson DA, Kelley M, et al. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. The Journal of Experimental Medicine, 1994, 179(1), 269-277. DOI: 10.1084/jem.179.1.269

[95]Yip MS, Leung NHL, Cheung CY, Li PH, Lee HHY, Daëron M, et al. Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus. Virology Journal, 2014, 11, 82. DOI: 10.1186/1743-422X-11-82

[96]Ghigo A, Li MC. Phosphoinositide 3-kinase: Friend and foe in cardiovascular disease. Frontiers in Pharmacology, 2015, 6, 169. DOI: 10.3389/fphar.2015.00169

[97]Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell, 2012, 149(5), 1060-1072. DOI: 10.1016/j.cell.2012.03.042

[98]Wei TF, Zhang J, Qin YH, Wu Y, Zhu L, Tang GS, et al. Increased expression of immunosuppressive molecules on intratumoral and circulating regulatory T cells in non-small-cell lung cancer patients. American Journal of Cancer Research, 2015, 5(7), 2190-2201.

[99]Dempke WCM, Fenchel K, Uciechowski P, Dale SP. Second- and third-generation drugs for immuno-oncology treatment-The more the better? European Journal of Cancer, 2017, 74, 55-72. DOI: 10.1016/j.ejca.2017.01.001

[100]Guo L, Li WB, Zhu XX, Ling Y, Qiu T, Dong L, et al. PD-L1 expression and CD274 gene alteration in triple-negative breast cancer: implication for prognostic biomarker. Springerplus, 2016, 5(1), 805. DOI: 10.1186/s40064-016-2513-x

[101]Holanda Pinto SA, Pinto LMS, Cunha GMA, Chaves MH, Santos FA, Rao VS. Anti-inflammatory effect of α, β-Amyrin, a pentacyclic triterpene from Protium heptaphyllum in rat model of acute periodontitis. Inflammopharmacology, 2008, 16, 48-52. DOI: 10.1007/s10787-007-1609-x

[102]Spano D, Zollo M. Tumor microenvironment: a main actor in the metastasis process. Clinical & Experimental Metastasis, 2012, 29, 381-395. DOI: 10.1007/s10585-012-9457-5

[103]Yang WJ, Hu JH, Uemura A, Tetzlaff F, Augustin HG, Fischer A. Semaphorin‐3C signals through Neuropilin‐1 and PlexinD1 receptors to inhibit pathological angiogenesis. EEMBO Molecular Medicine, 2015, 7, 1267-1284. DOI: 10.15252/emmm.201404922

[104]West DC, Hampson IN, Arnold F, Kumar S. Angiogenesis induced by degradation products of hyaluronic acid. Science, 1985, 228(4705), 1324-1326. DOI: 10.1126/science.2408340

[105]Sun LJ, Liu JW, Cui DL, Li JY, Yu YJ, Ma L, et al. Anti‐inflammatory function of Withangulatin A by targeted inhibiting COX‐2 expression via MAPK and NF‐κB pathways. Journal of Cellular Biochemistry, 2010, 109(3), 532-541. DOI: 10.1002/jcb.22430

[106]Pereira Beserra F, Xue M, Maia GL de A, Rozza LA, Pellizzon CH, JacksonCJ. Lupeol, a pentacyclic triterpene, promotes migration, wound closure, and contractile effect in vitro: Possible involvement of PI3K/Akt and p38/ERK/MAPK pathways. Molecules, 2018, 23(11), 2819. DOI: 10.3390/molecules23112819

[107]Hahn AW, Gill DM, Pal SK, Agarwal N. The future of immune checkpoint cancer therapy after PD-1 and CTLA-4. Immunotherapy, 2017, 9(8), 681-692. DOI: 10.2217/imt-2017-0024

[108]Hozhabri H, Moghaddam MM, Moghaddam MM, Mohammadian A. A comprehensive bioinformatics analysis to identify potential prognostic biomarkers among CC and CXC chemokines in breast cancer. Scientific Reports, 2022, 12(1), 10374. DOI: 10.1038/s41598-022-14610-2

[109]Zhang J, Huang JZ, Zhang YQ, Zhang X, Zhao LY, Li CG, et al. Microtubule associated protein 9 inhibits liver tumorigenesis by suppressing ERCC3. EBioMedicine, 2020, 53, 102701. DOI: 10.1016/j.ebiom.2020.102701

[110]Cao Y, Gong Y, Liu LL, Zhou YW, Fang X, Zhang C, et al. The use of human umbilical vein endothelial cells (HUVECs) as an in vitro model to assess the toxicity of nanoparticles to endothelium: A review. Journal of Applied Toxicology, 2017, 37(12), 1359-1369. DOI: 10.1002/jat.3470

[111]Hu YF, Zeng N, Ge YQ, Wang D, Qin XX, Zhang WS, et al. Identification of the shared gene signatures and biological mechanism in type 2 diabetes and pancreatic cancer. Frontiers in Endocrinology, 2022, 13, 847760. DOI: 10.3389/fendo.2022.847760

[112]Yong LK, Lai S, Liang ZD, Poteet E, Chen FJ, van Buren G, et al. Overexpression of Semaphorin-3E enhances pancreatic cancer cell growth and associates with poor patient survival. Oncotarget, 2016, 7(52), 87431-87448. DOI: 10.18632/oncotarget.13704

[113]Lee W, Ahn JH, Park HH, Kim HN, Kim H, Yoo Y, et al. COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm. Signal Transduction and Targeted Therapy, 2020, 5, 186. DOI: 10.1038/s41392-020-00292-7

[114]Naeem A, Waseem A, Siddiqui AJ, Ray B, Sinha R, Khan AQ, et al. Focusing on the cytokine storm in the battle against COVID-19: The rising role of mesenchymal-derived stem cells. Stem Cells, 2024, 191-207. DOI: 10.1016/B978-0-323-95545-4.00008-6

[115]Liu L, Koike H, Ono T, Hayashi S, Kudo F, Kaneda A, et al. Identification of a KLF5-dependent program and drug development for skeletal muscle atrophy. Proceedings of the National Academy of Sciences of the United States of America, 2021, 118(35), e2102895118. DOI: 10.1073/pnas.2102895118

[116]Cesari M, Fielding RA, Pahor M, Goodpaster B, Hellerstein M, van Kan GA, et al. Biomarkers of sarcopenia in clinical trials-recommendations from the international working group on sarcopenia. Journal of Cachexia, Sarcopenia and Muscle, 2012, 3(3), 181-190. DOI: 10.1007/s13539-012-0078-2

[117]Signorelli M, Ayoglu B, Johansson C, Lochmüller H, Straub V, Muntoni F, et al. Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy. Journal of Cachexia, Sarcopenia and Muscle, 2020, 11(2), 505-517. DOI: 10.1002/jcsm.12517

[118]Cui HY, He GY, Yang S, Lv Y, Jiang ZM, Gang XK, et al. Inappropriate antidiuretic hormone secretion and cerebral salt-wasting syndromes in neurological patients. Frontiers in Neuroscience, 2019, 13, 1170. DOI: 10.3389/fnins.2019.01170

[119]Rood JE. The role of antigen-independent signals in CD8+ T cell responses in hemophagocytic syndromes. University of Pennsylvania, 2018.

[120]Dombrowski Y, Peric M, Koglin S, Kammerbauer C, Göss C, Anz D, et al. Cytosolic DNA triggers inflammasome activation in keratinocytes in psoriatic lesions. Science Translational Medicine, 2011, 3(82), 82ra38-82ra38. DOI: 10.1126/scitranslmed.3002001

[121]Logie E, Van Puyvelde B, Cuypers B, Schepers A, Berghmans H, Verdonck J, et al. Ferroptosis induction in multiple myeloma cells triggers DNA methylation and histone modification changes associated with cellular senescence. International Journal of Molecular Sciences, 2021, 22(22), 12234. DOI: 10.3390/ijms222212234

[122]Manzoor U, Ali A, Ali SL, Abdelkarem O, Kanwal S, Alotaibi SS, et al (2023) Mutational screening of GDAP1 in dysphonia associated with Charcot-Marie-Tooth disease: Clinical insights and phenotypic effects. Journal of Genetic Engineering and Biotechnology, 21(1), 119. DOI: 10.1186/s43141-023-00568-9

[123]Barsanti C, Trivella MG, D’Aurizio R, El Baroudi M, Baumgart M, Groth M, et al. Differential regulation of microRNAs in end-stage failing hearts is associated with left ventricular assist device unloading. BioMed Research International, 2015, 2015, 592512. DOI: 10.1155/2015/592512

[124]Narayana SK, Talab SK, Elrishi MA. Liraglutide-induced acute kidney injury. Practical Diabetes, 2012. DOI: 10.1002/pdi.1727

[125]Bagchi S, Yuan R, Engleman EG. Immune checkpoint inhibitors for the treatment of cancer: Clinical impact and mechanisms of response and resistance. Annual Review Pathology, 16, 223-249. DOI: 10.1146/annurev-pathol-042020-042741

[126]Zhu F, Tan CX, Li CH, Ma SY, Wen HC,Yang H, et al. Design of a multi-epitope vaccine against six Nocardia species based on reverse vaccinology combined with immunoinformatics. Frontiers in Immunology, 2023, 14, 1100188. DOI: 10.3389/fimmu.2023.1100188

[127]Demeure CE, Wolfers J, Martin-Garcia N, Gaulard P, Triebel F. T Lymphocytes infiltrating various tumour types express the MHC class II ligand lymphocyte activation gene-3 (LAG-3): role of LAG-3/MHC class II interactions in cell-cell contacts. European Journal of Cancer, 2001, 37(13), 1709-1718. DOI: 10.1016/s0959-8049(01)00184-8

[128]Juno JA, Stalker AT, Waruk JL, Oyugi J, Kimani M, Plummer FA, et al. Elevated expression of LAG-3, but not PD-1, is associated with impaired iNKT cytokine production during chronic HIV-1 infection and treatment. Retrovirology, 2015, 12, 17. DOI: 10.1186/s12977-015-0142-z

[129]Okazaki T, Okazaki I, Wang J, Sugiura D, Nakaki F, Yoshida T, et al. PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice. The Journal of Experimental Medicine, 2011, 208(2), 395-407. DOI: 10.1084/jem.20100466

[130]Brahmer JR, Tykodi SS, Chow LQM, Hwu WJ, Topalian SL, Hwu P, et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. The New England Journal of Medicine, 2012, 366(26), 2455-2465. DOI: 10.1056/NEJMoa1200694

[131]Martínez-Pérez A, Granda-Díaz R, Aguilar-García C, Sordo-Bahamonde C, Gonzalez S. Deciphering LAG-3: Unveiling molecular mechanisms and clinical advancements. Biomarker Research, 2024, 12(1), 126. DOI: 10.1186/s40364-024-00671-0

[132]Bettini M, Szymczak-Workman AL, Forbes K, Castellaw AH, Selby M, Pan XY, et al. Cutting edge: Accelerated autoimmune diabetes in the absence of LAG-3. Journal of Immunology, 2011, 187(7), 3493-3498. DOI: 10.4049/jimmunol.1100714

[133]Baumeister SH, Freeman GJ, Dranoff G, Sharpe AH. Coinhibitory pathways in immunotherapy for cancer. Annual Review of Immunology, 2016, 34, 539-573. DOI: 10.1146/annurev-immunol-032414-112049

[134]Camisaschi C, Casati C, Rini F, Perego M. LAG-3 expression defines a subset of CD4(+)CD25(high)Foxp3(+) regulatory T cells that are expanded at tumor sites. The Journal of Immunology, 2010, 184(11), 6545-6551. DOI: 10.4049/jimmunol.0903879

[135]Zou WP. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nature Reviews Cancer, 2005, 5, 263-274. DOI: 10.1038/nrc1586

[136]Lino AC, Dang VD, Lampropoulou V, Welle A, Joedicke J, Pohar J, et al. LAG-3 inhibitory receptor expression identifies immunosuppressive natural regulatory plasma cells. Immunity, 2018, 49(1), 120-133.e9. DOI: 10.1016/j.immuni.2018.06.007

[137]Atukpa ME, Okeke EO, Falade MO, Ali A, Ali SL, Hajar A, et al. Genetic identification and determination of parasites (babesia, leptospira and toxoplasma gondi) in wild rats. 2024. DOI: 10.21203/rs.3.rs-3765664/v1

[138]Dhodapkar KM, Kaufman JL, Ehlers M, Banerjee DK, Bonvini E, Koenig S, et al. Selective blockade of inhibitory Fcγ receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells. Proceedings of the National Academy of Sciences of the United States of America, 2005, 102(8), 2910-2915. DOI: 10.1073/pnas.0500014102

[139]Hargadon KM. Tumor-altered dendritic cell function: implications for anti-tumor immunity. Frontiers in Immunology, 2013, 4, 192. DOI: 10.3389/fimmu.2013.00192

[140]Sheppard M, Laskou F, Stapleton PP, Hadavi S, Dasgupta B. Tocilizumab (actemra). Human Vaccines & Immunotherapeutics, 2017, 13(9), 1972-1988. DOI: 10.1080/21645515.2017.1316909

[141]Obeng JA, Amoruso A, Camaschella GLE, Sola D, Brunelleschi S, Fresu LG. Modulation of human monocyte/macrophage activity by tocilizumab, abatacept and etanercept: An in vitro study. European Journal of Pharmacology, 2016, 780, 33-37. DOI: 10.1016/j.ejphar.2016.03.028

[142]Narula N, Wong ECL, Marshall JK, Colombel JF, Dulai PS, Reinisch W. Comparative efficacy for infliximab vs vedolizumab in biologic naive ulcerative colitis. Clinical Gastroenterology and Hepatology, 2022, 20(7), 1588-1597. DOI: 10.1016/j.cgh.2021.07.038

[143]Krithika R, Jyothilakshmi V, Verma RJ. Phyllanthin inhibits CCl4-mediated oxidative stress and hepatic fibrosis by down-regulating TNF-α/NF-κB, and pro-fibrotic factor TGF-β1 mediating inflammatory signaling. Toxicology and Industrial Health, 2016, 32(5), 953-960.DOI: 10.1177/0748233714532996

[144]Tada T, Fan C, Chen JS, Kaur R, Stapleford KA, Gristick, et al. An ACE2 microbody containing a single immunoglobulin Fc domain is a potent inhibitor of SARS-CoV-2. Cell Reports, 2020, 33(12), 108528. DOI: 10.1016/j.celrep.2020.108528

[145]Sun YF, Wu L, Liu SP, Jiang MM, Hu B, Zhou KQ, et al. Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinoma. Nature Communications, 2021, 12, 4091. DOI: 10.1038/s41467-021-24386-0

[146]Holdt LM, Hoffmann S, Sass K, Langenberger D, Scholz M, Krohn K, et al. Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regulation of gene networks. PLoS Genetics, 9(7), e1003588. DOI: 10.1371/journal.pgen.1003588

[147]Pavel I, Irina L, Tatiana G, Denis P, Philipp K, Sergei K, et al. Comparison of the illumina nextSeq 2000 and geneMind genolab M sequencing platforms for spatial transcriptomics. BMC Genomics, 2023, 24, 102. DOI: 10.1186/s12864-023-09192-w

[148]Wang SC, Li Y, He LQ, Yang J, Fernie AR, Luo J. Natural variance at the interface of plant primary and specialized metabolism. Current Opinion in Plant Biology, 2022, 67, 102201. DOI: 10.1016/j.pbi.2022.102201

[149]Zhang WT, Zeng Y, Jiao M, Ye CJ, Li YR, Liu CG, et al. Integration of high-throughput omics technologies in medicinal plant research: The new era of natural drug discovery. Frontiers in Plant Science, 2023, 14, 1073848. DOI: 10.3389/fpls.2023.1073848

[150]Zhang SR, Zeng XN, Lin SN, Liang MC, Huang HX. Identification of seven‐gene marker to predict the survival of patients with lung adenocarcinoma using integrated multi‐omics data analysis. Journal of Clinical Laboratory Analysis, 2022, 36(2), e24190. DOI: 10.1002/jcla.24190

[151]Wang CB, He Y, Zheng J, Wang X, Chen SH. Dissecting order amidst chaos of programmed cell deaths: construction of a diagnostic model for KIRC using transcriptomic information in blood-derived exosomes and single-cell multi-omics data in tumor microenvironment. Frontiers in Immunology, 2023, 14, 1130513. DOI: 10.3389/fimmu.2023.1130513

Downloads

Published

2026-07-03

Issue

Vol. 1 No. 2 (2026)

Section

Articles

License

Copyright (c) 2026 Awais Ali (Author)

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

Ali, A. (2026). Cytokine Storms and Silent Killers: Immune Dysregulation in Cancer Progression. Clinical Medicine and Integrative Therapies, 1(2), 1-16. https://doi.org/10.64229/74pkkk80